N Schaschke|I Assfalg-Machleidt|T Lassleben|C P Sommerhoff|L Moroder|W Machleidt - JoVE Visualize

Showing results (1-10 of 304) with videos related to

Pageof 31

Sort By:

FEBS Letters|October 6, 2000

Epoxysuccinyl peptide-derived affinity labels for cathepsin BN Schaschke, I Assfalg-Machleidt, T Lassleben, et al.

Bioorganic & Medicinal Chemistry Letters|April 13, 2000

Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cellsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

FEBS Letters|February 14, 1998

Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitorsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

Bioorganic & Medicinal Chemistry|November 14, 1997

E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl groupN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

FEBS Letters|August 12, 1996

Cyclodextrins as templates for the presentation of protease inhibitorsN Schaschke, H J Musiol, I Assfalg-Machleidt, et al.

Current Pharmaceutical Design|February 23, 2007

Mast cell tryptase beta as a target in allergic inflammation: an evolving storyC P Sommerhoff, N Schaschke

Biological Chemistry Hoppe-Seyler|May 1, 1988

Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumorsI Assfalg-Machleidt, M Jochum, W Klaubert, et al.

Biomedica Biochimica Acta|January 1, 1991

Proteolysis of defensive proteins in peritonitis exudate: pathobiochemical aspects and therapeutical approachA Billing, D Fröhlich, I Assfalg-Machleidt, et al.

The Journal of Biological Chemistry|September 5, 1988

Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctionsR Vogel, I Assfalg-Machleidt, A Esterl, et al.

Biomedica Biochimica Acta|January 1, 1991

Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefinsW Machleidt, U Thiele, I Assfalg-Machleidt, et al.

Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:

Pageof 31

FEBS Letters|October 6, 2000

Epoxysuccinyl peptide-derived affinity labels for cathepsin BN Schaschke, I Assfalg-Machleidt, T Lassleben, et al.

Bioorganic & Medicinal Chemistry Letters|April 13, 2000

Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cellsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

FEBS Letters|February 14, 1998

Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitorsN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

Bioorganic & Medicinal Chemistry|November 14, 1997

E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl groupN Schaschke, I Assfalg-Machleidt, W Machleidt, et al.

FEBS Letters|August 12, 1996

Cyclodextrins as templates for the presentation of protease inhibitorsN Schaschke, H J Musiol, I Assfalg-Machleidt, et al.

Current Pharmaceutical Design|February 23, 2007

Mast cell tryptase beta as a target in allergic inflammation: an evolving storyC P Sommerhoff, N Schaschke

Biological Chemistry Hoppe-Seyler|May 1, 1988

Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumorsI Assfalg-Machleidt, M Jochum, W Klaubert, et al.

Biomedica Biochimica Acta|January 1, 1991

Proteolysis of defensive proteins in peritonitis exudate: pathobiochemical aspects and therapeutical approachA Billing, D Fröhlich, I Assfalg-Machleidt, et al.

The Journal of Biological Chemistry|September 5, 1988

Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctionsR Vogel, I Assfalg-Machleidt, A Esterl, et al.

Biomedica Biochimica Acta|January 1, 1991

Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefinsW Machleidt, U Thiele, I Assfalg-Machleidt, et al.

Pageof 31